Development and validation of a simple and rapid way to generate low volume of plasma to be used in point-of-care HIV virus load technologies
Braz. j. infect. dis; 24 (1), 2020
ABSTRACT A new point-of-care HIV viral load, mPIMA HIV-1/2 VL, Abbott, USA, has been recently developed. This point-of-care viral load requires no skilled person to run and uses a small plasma volume (50 µL). However, obtaining 50 µL of plasma can be a challenge in limited resource settings. We validat...